ESMO 2018: Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 19 October 2018

Biliary Tract Cancer: Current Status & Future Prospects

Biliary Tract Cancer: Current Status & Future Prospects Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Checkpoint Inhibition in the Treatment of Cancer: Building the New Standard of Care Across Multiple Solid Tumors and Understanding the Role of Pembrolizumab

MSD Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

Comprehensive Genomic Profiling: Taking Precision Medicine from Vision to Reality

Comprehensive Genomic Profiling: Taking Precision Medicine from Vision to Reality Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Immunotherapy in Daily Clinical Practice: Clinical Application and Emerging Opportunities

Immunotherapy in Daily Clinical Practice: Clinical Application and Emerging Opportunities Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

Navigating New Waters in mRCC

Navigating New Waters in mRCC Thumbnail

Friday, 18:00 - 19:30
View the satellite invitation

Precision Medicine in Oncology Care: Using Every Available Tool

Precision Medicine in Oncology Car: Using Every Available Tool Thumbnail

Friday, 18:00 - 19:30
View the satellite invitation

The Future Is Now: Innovations in I-O for First-Line Advanced Renal Cell Carcinoma

The Future Is Now: Innovations in I-O for First-Line Advanced Renal Cell Carcinoma Thumb

Friday, 18:00 - 20:00
View the satellite invitation

The Path to Precision Medicine—Accelerating Science and Evolving Oncology Treatment Paradigms

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Friday, 18:00 - 20:00
View the satellite invitation

The Rise in Oncology Biosimilars: From Process to Promise

The Rise in Oncology Biosimilars: From Process to Promise Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno-Oncology

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Trastuzumab Biosimilar for Tomorrow

Trastuzumab Biosimilar for Tomorrow Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

Women for Mankind: Optimal Use of Chemotherapy in Metastatic Prostate Cancer

Women for Mankind: Optimal Use of Chemotherapy in Metastatic Prostate Cancer Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

Saturday 20 October 2018

Considerations as We Treat mCRPC Earlier

Considerations as We Treat mCRPC Earlier Thumbnail

Saturday, 13:00 - 14:30
View the satellite invitation

Global Perspectives on Optimal Treatment for HR+, HER2– Advanced Breast Cancer

Global Perspectives on Optimal Treatment for HR+, HER2– Advanced Breast Cancer Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

HER2 Expression in Metastatic Breast Cancer: A Paradigm Shift?

HER2 Expression in Metastatic Breast Cancer: A Paradigm Shift? Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Looking Beyond the Obvious in Management of Advanced RCC

Looking Beyond the Obvious in Management of Advanced RCC Thumbnail

Saturday, 13:00 - 14:30
View the satellite invitation

Mapping the Optimal Treatment Sequence in mCRC

Mapping the Optimal Treatment Sequence in mCRC Thumbnail

Saturday, 13:00 - 14:30
View the satellite invitation

Setting a New Standard of Care in Advanced Lung Cancer

MSD Thumbnail

Saturday, 13:00 - 14:30
View the satellite invitation

Treating Pretreated mCRC and mGC: Management Strategies for Better Patient Outcomes

Treating Pretreated mCRC And mGC: Management Strategies for Better Patient Outcomes Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Optimizing Evidence-Based Treatment Planning with Multikinase Inhibition in mCRC and uHCC

Optimizing Evidence-Based Treatment Planning With Multikinase Inhibition in mCRC and uHCC Thumbnail

Saturday, 18:30 - 20:00
View the satellite invitation

Prediction with Precision: Does TAILORx Make Chemotherapy a Personalized Treatment?

Prediction with Precision: Does Tailorx Make Chemotherapy a Personalized Treatment? Thumbnail

Saturday, 18:30 - 20:00
View the satellite invitation

The Evolving Landscape of Treating Cancer-Associated Thrombosis (CAT): From LMWH to Direct Oral Anticoagulants (DOACs)?

The Evolving Landscape of Treating Cancer-Associated Thrombosis (CAT): From LMWH to Direct Oral Anticoagulants (DOACs)? Thumbnail

Saturday, 18:30 - 20:00
View the satellite invitation

Scaling New Heights in Breast Cancer Care

Scaling New Heights in Breast Cancer Care Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Sunday 21 October 2018

CDK Inhibitor Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer Clinical Characteristics and Choices

CDK Inhibitor Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer Clinical Characteristics and Choices Thumbnail

Sunday 13:00 - 14:30
View the satellite invitation

EGFR-Mutated NSCLC: A Data-Driven Approach to Optimising Patient Outcomes

EGFR-Mutated NSCLC: A Data-Driven Approach to Optimising Patient Outcomes Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Is Earlier Better? Translating Clinical Evidence into Individualised Treatment Decisions in Advanced Prostate Cancer

Is Earlier Better? Translating Clinical Evidence into Individualised Treatment Decisions in Advanced Prostate Cancer Thumbnail

Sunday, 13:00 - 14:30
View the satellite invitation

New Options for HER2+ Breast Cancer: Building on Success

Immunotherapy in Daily Clinical Practice: Clinical Application and Emerging Opportunities Thumbnail

Sunday, 13:00 - 14:30
View the satellite invitation

PARP Inhibitors: Opening the Door to New Treatment Options in Recurrent Ovarian Cancer

PARP Inhibitors: Opening the Door to New Treatment Options in Recurrent Ovarian Cancer Thumbnail

Sunday, 13:00 - 14:30
View the satellite invitation

Treating Lung Cancer in a Rapidly Evolving Landscape

Treating Lung Cancer in a Rapidly Evolving Landscape Thumbnail

Sunday, 13:00 - 14:30
View the satellite invitation

Expanding Horizons in Lung Cancer Treatment: New Data and Emerging Biomarkers

Expanding Horizons in Lung Cancer Treatment: New Data and Emerging Biomarkers Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Getting the Best Out of Targeted Therapies for ALK+ NSCLC: Practical Insights on Choices and Trade-Offs

Getting the Best Out of Targeted Therapies for ALK+ NSCLC: Practical Insights on Choices and Trade-Offs Thumbnail

Sunday, 18:30 - 20:00
View the satellite invitation

Navigating the Treatment Sequence for Patients Living with Nets. Do You Have Enough Evidence to Support Clinical Decisions?

Navigating the Treatment Sequence for Patients Living with Nets. Do You Have Enough Evidence to Support Clinical Decisions? Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Sequencing Life-Prolonging Agents in Prostate Cancer

Sequencing Life-Prolonging Agents in Prostate Cancer Thumbnail

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 22 October 2018

Changing the Natural Disease Course in Ovarian Cancer: The Role of PARPi Maintenance

Changing the Natural Disease Course in Ovarian Cancer: The Role of PARPi Maintenance Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

Changing the Natural History of Breast Cancer: Where are We, and What’s Next in HER2-Positive and Triple-Negative Disease?

Changing the Natural History of Breast Cancer: Where are We, and What’s Next in HER2-Positive and Triple-Negative Disease? Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

From Early to Advanced Melanoma: An Oncologist’s View of Systemic Treatment Opportunities

The Future Is Now: Innovations in I-O for First-Line Advanced Renal Cell Carcinoma Thumb

Monday, 13:00 - 14:30
View the satellite invitation

From Revolution to Evolution: What’s Next for Checkpoint Inhibition in Solid Tumours?

From Revolution to Evolution: What’s Next for Checkpoint Inhibition in Solid Tumours? Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

How Do We Improve Treatment Outcomes of Patients with BRAF-Positive Metastatic Melanoma?

How Do We Improve Treatment Outcomes of Patients With BRAF-positive Metastatic Melanoma Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

How Immunotherapy is Revolutionising First-Line Lung Cancer Care

How Immunotherapy is Revolutionising First-Line Lung Cancer Care Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Maximising Patient Outcomes Through Evidence-Based Decision-Making in Advanced Gastric and GEJ Cancer

Maximising Patient Outcomes Through Evidence Based Decision Making In Advanced Gastric and Gej Cancer Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Joining Together to Improve Overall Survival in Oncogenic-Driven NSCLC

Joining Together to Improve Overall Survival in Oncogenic-Driven NSCLC Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

Biomarkers in Lung Cancer: Targeting the Right Patient with the Right Therapy

Biomarkers in Lung Cancer: Targeting the Right Patient with the Right Therapy Thumbnail

Monday, 18:30 - 20:00
View the satellite invitation

Evolution of Immunotherapy and the Road Ahead in HNSCC

MSD Thumbnail

Monday, 18:30 - 20:00
View the satellite invitation

Innovative Targeted Therapies in NSCLC and Beyond

Innovative Targeted Therapies in NSCLC and Beyond Thumb

Monday, 18:30 - 20:00
View the satellite invitation

PARP Inhibition in Ovarian Cancer: Is it Time for a Paradigm Shift?

PARP Inhibition in Ovarian Cancer: Is it Time for a Paradigm Shift? Thumbnail

Monday, 18:30 - 20:00
View the satellite invitation

Precision Immuno-Oncology: Driving Patient Selection and Clinical Care Through Biomarker Testing

Precision Immuno-Oncology: Driving Patient Selection and Clinical Care Through Biomarker Testing Thumb

Monday, 18:30 - 20:00
View the satellite invitation

Treating Cancer-Associated Thrombosis Today New Concepts and Perspectives

Treating Cancer-Associated Thrombosis Today New Concepts and Perspectives Thumbnail

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the Complete ESMO 2018 Industry Satellite Symposia Programme